{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:39:50Z","timestamp":1742805590901},"reference-count":97,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10593","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T07:04:21Z","timestamp":1628665461000},"source":"Crossref","is-referenced-by-count":2,"title":["Crosstalk of fibroblast growth factor 23 and anemia\u2011related factors during the development and progression of CKD (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Changchun University of Chinese medicine, Changchun, Jilin 130000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Changchun University of Chinese medicine, Changchun, Jilin 130000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"key20210903112719_b1-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"key20210903112719_b2-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"key20210903112719_b3-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key20210903112719_b4-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","article-title":"Disordered FGF23 and mineral metabolism in children with CKD","volume":"9","author":"Portale","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20210903112719_b5-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MNH.0000000000000240","article-title":"Multiple faces of fibroblast growth factor-23","volume":"25","author":"Han","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20210903112719_b6-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20210903112719_b7-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J Bone Miner Res"},{"key":"key20210903112719_b8-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"key20210903112719_b9-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","article-title":"Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice","volume":"311","author":"Hanudel","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20210903112719_b10-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","article-title":"Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow","volume":"102","author":"Clinkenbeard","year":"2017","journal-title":"Haematologica"},{"key":"key20210903112719_b11-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"F132","DOI":"10.1152\/ajprenal.00081.2017","article-title":"Acute blood loss stimulates fibroblast growth factor 23 production","volume":"314","author":"Rabadi","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"e0186979","key":"key20210903112719_b12-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186979","article-title":"FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase","volume":"12","author":"Flamme","year":"2017","journal-title":"PLoS One"},{"key":"key20210903112719_b13-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","article-title":"Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury","volume":"93","author":"Toro","year":"2018","journal-title":"Kidney Int"},{"key":"key20210903112719_b14-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1210\/jc.2016-2215","article-title":"Fibroblast growth factor 23 and cause-specific mortality in the general population: The Northern Manhattan Study","volume":"101","author":"Souma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210903112719_b15-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"key20210903112719_b16-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20210903112719_b17-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"Jama"},{"key":"key20210903112719_b18-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"key20210903112719_b19-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00467-014-2820-9","article-title":"Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis","volume":"29","author":"Lestz","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"118","key":"key20210903112719_b20-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00118","article-title":"Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the Nefrona Cohort","volume":"10","author":"Valls","year":"2019","journal-title":"Front Genet"},{"key":"key20210903112719_b21-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1096\/fj.201700667R","article-title":"Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia","volume":"32","author":"Agoro","year":"2018","journal-title":"FASEB J"},{"key":"key20210903112719_b22-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/nu3030283","article-title":"Iron, meat and health","volume":"3","author":"Geissler","year":"2011","journal-title":"Nutrients"},{"issue":"1327","key":"key20210903112719_b23-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121327","article-title":"Iron supplementation during pregnancy and infancy: Uncertainties and implications for research and policy","volume":"9","author":"Brannon","year":"2017","journal-title":"Nutrients"},{"key":"key20210903112719_b24-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1503\/cmaj.050342","article-title":"Malnutrition and health in developing countries","volume":"173","author":"M\u00fcller","year":"2005","journal-title":"CMAJ"},{"key":"key20210903112719_b25-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10995-005-0036-0","article-title":"Child food insecurity and iron deficiency anemia in low-income infants and toddlers in the United States","volume":"10","author":"Skalicky","year":"2006","journal-title":"Matern Child Health J"},{"key":"key20210903112719_b26-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00394-011-0212-5","article-title":"Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats","volume":"51","author":"D\u00edaz-Castro","year":"2012","journal-title":"Eur J Nutr"},{"key":"key20210903112719_b27-etm-0-0-10593","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.103.2664.72","article-title":"The anemia associated with chronic infection","volume":"103","author":"Cartwright","year":"1946","journal-title":"Science"},{"key":"key20210903112719_b28-etm-0-0-10593","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI101690","article-title":"The anemia of infection; hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients","volume":"25","author":"Cartwright","year":"1946","journal-title":"J Clin Invest"},{"key":"key20210903112719_b29-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"304","DOI":"10.12669\/pjms.312.6462","article-title":"Malabsorption of iron as a cause of iron deficiency anemia in postmenopausal women","volume":"31","author":"Qamar","year":"2015","journal-title":"Pak J Med Sci"},{"key":"key20210903112719_b30-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.MIB.0000442728.74340.fd","article-title":"Prevalence of anemia in inflammatory bowel diseases in european countries: A systematic review and individual patient data meta-analysis","volume":"20","author":"Filmann","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key20210903112719_b31-etm-0-0-10593","first-page":"161","article-title":"Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron","volume":"19","author":"Gotloib","year":"2006","journal-title":"J Nephrol"},{"key":"key20210903112719_b32-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.blre.2009.09.001","article-title":"Anemia in renal disease: Diagnosis and management","volume":"24","author":"Lankhorst","year":"2010","journal-title":"Blood Rev"},{"key":"key20210903112719_b33-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2215\/CJN.03950417","article-title":"Fibroblast growth factor 23 and anemia in the chronic renal insufficiency cohort study","volume":"12","author":"Mehta","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20210903112719_b34-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1681\/ASN.2016121350","article-title":"C-terminal fibroblast growth factor 23, iron deficiency, and mortality in renal transplant recipients","volume":"28","author":"Eisenga","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key20210903112719_b35-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: Iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20210903112719_b36-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1074\/jbc.M413248200","article-title":"Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins","volume":"280","author":"McMahon","year":"2005","journal-title":"J Biol Chem"},{"issue":"e1002818","key":"key20210903112719_b37-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002818","article-title":"Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study","volume":"16","author":"Eisenga","year":"2019","journal-title":"PLoS Med"},{"key":"key20210903112719_b38-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.emc.2014.04.007","article-title":"Anemia","volume":"32","author":"Vieth","year":"2014","journal-title":"Emerg Med Clin North Am"},{"key":"key20210903112719_b39-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.hoc.2012.02.008","article-title":"Why is my patient anemic?","volume":"26","author":"Bryan","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20210903112719_b40-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/toxsci\/kfu043","article-title":"Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells","volume":"139","author":"Kido","year":"2014","journal-title":"Toxicol Sci"},{"key":"key20210903112719_b41-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2017.02.005","article-title":"Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study","volume":"98","author":"Lewerin","year":"2017","journal-title":"Bone"},{"key":"key20210903112719_b42-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00359.2016","article-title":"Ironing out the cross talk between FGF23 and inflammation","volume":"312","author":"David","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20210903112719_b43-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2215\/CJN.09570912","article-title":"Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology","volume":"8","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20210903112719_b44-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"key20210903112719_b45-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3345","key":"key20210903112719_b46-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02709-w","article-title":"FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts","volume":"7","author":"Smith","year":"2017","journal-title":"Sci Rep"},{"key":"key20210903112719_b47-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"key20210903112719_b48-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J Clin Invest"},{"key":"key20210903112719_b49-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-13-1550","article-title":"Targeting fibroblast growth factor pathways in prostate cancer","volume":"19","author":"Corn","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20210903112719_b50-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20210903112719_b51-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"17291","DOI":"10.18632\/oncotarget.4174","article-title":"FGF23 promotes prostate cancer progression","volume":"6","author":"Feng","year":"2015","journal-title":"Oncotarget"},{"key":"key20210903112719_b52-etm-0-0-10593","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2169\/naika.71.1566","article-title":"2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide","volume":"71","author":"Okada","year":"1982","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"key20210903112719_b53-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: An updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key20210903112719_b54-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.jrn.2017.12.009","article-title":"Oral versus intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis-effect on fibroblast growth factor-23 metabolism","volume":"28","author":"Fukao","year":"2018","journal-title":"J Ren Nutr"},{"key":"key20210903112719_b55-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2015.10.001","article-title":"Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat","volume":"766","author":"Taniguchi","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key20210903112719_b56-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/nep.12891","article-title":"Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study","volume":"22","author":"Koiwa","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"key20210903112719_b57-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/ndt\/gfw242","article-title":"Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide","volume":"32","author":"Covic","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"363","key":"key20210903112719_b58-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3483-6","article-title":"Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients","volume":"11","author":"Shima","year":"2018","journal-title":"BMC Res Notes"},{"key":"key20210903112719_b59-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ndt\/17.2.265","article-title":"An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: Ferric citrate","volume":"17","author":"Yang","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key20210903112719_b60-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40620-014-0108-6","article-title":"Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: Multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"Lee","year":"2015","journal-title":"J Nephrol"},{"key":"key20210903112719_b61-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000489964","article-title":"Ferric citrate decreases fibroblast growth factor 23 and improves erythropoietin responsiveness in hemodialysis patients","volume":"47","author":"Maruyama","year":"2018","journal-title":"Am J Nephrol"},{"key":"key20210903112719_b62-etm-0-0-10593"},{"key":"key20210903112719_b63-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key20210903112719_b64-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1248\/cpb.35.271","article-title":"Chemical characterization of rabbit alpha 2-macroglobulin","volume":"35","author":"Hinata","year":"1987","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"e0196684","key":"key20210903112719_b65-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196684","article-title":"The hypoxia inducible factor\/erythropoietin (EPO)\/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia","volume":"13","author":"Landau","year":"2018","journal-title":"PLoS One"},{"key":"key20210903112719_b66-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1007\/s00592-004-0132-4","article-title":"Anaemia in diabetes","volume":"41 (Suppl 1)","author":"Thomas","year":"2004","journal-title":"Acta diabetologica"},{"key":"key20210903112719_b67-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00424-018-2171-7","article-title":"Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men","volume":"470","author":"Daryadel","year":"2018","journal-title":"Pflugers Arch"},{"key":"key20210903112719_b68-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/ndt\/gfy189","article-title":"Effects of erythropoietin on fibroblast growth factor 23 in mice and humans","volume":"34","author":"Hanudel","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"e011130","key":"key20210903112719_b69-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011130","article-title":"Epoetin Beta and C-terminal fibroblast growth factor 23 in patients with chronic heart failure and chronic kidney disease","volume":"8","author":"Eisenga","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"key20210903112719_b70-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of disease: Erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"van der Putten","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"key20210903112719_b71-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20210903112719_b72-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.3324\/haematol.2016.150987","article-title":"Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease","volume":"102","author":"Courbebaisse","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"key20210903112719_b73-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-017-0167-y","article-title":"HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma","volume":"5","author":"Miikkulainen","year":"2017","journal-title":"Cancer Metab"},{"key":"key20210903112719_b74-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.molcel.2017.06.002","article-title":"The EGLN-HIF O2-sensing system: Multiple inputs and feedbacks","volume":"66","author":"Ivan","year":"2017","journal-title":"Mol Cell"},{"key":"key20210903112719_b75-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yexcr.2017.03.008","article-title":"New horizons in hypoxia signaling pathways","volume":"356","author":"Pugh","year":"2017","journal-title":"Exp Cell Res"},{"key":"key20210903112719_b76-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1152\/physiol.00022.2015","article-title":"Oxygen sensing and homeostasis","volume":"30","author":"Prabhakar","year":"2015","journal-title":"Physiology (Bethesda)"},{"key":"key20210903112719_b77-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneph.2015.193","article-title":"HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond","volume":"12","author":"Maxwell","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"key20210903112719_b78-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.kint.2016.08.016","article-title":"HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease","volume":"90","author":"Wyatt","year":"2016","journal-title":"Kidney Int"},{"key":"key20210903112719_b79-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00223-016-0206-7","article-title":"Novel faces of fibroblast growth factor 23 (FGF23): Iron deficiency, inflammation, insulin resistance, left ventricular hypertrophy, proteinuria and acute kidney injury","volume":"100","author":"Kanbay","year":"2017","journal-title":"Calcif Tissue Int"},{"issue":"592","key":"key20210903112719_b80-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00592","article-title":"Osteocytic FGF23 and its kidney function","volume":"11","author":"Agoro","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20210903112719_b81-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2215\/CJN.06890615","article-title":"Oral hypoxia-inducible factor Prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD","volume":"11","author":"Provenzano","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20210903112719_b82-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s11914-018-0492-2","article-title":"Non-renal-Related Mechanisms of FGF23 Pathophysiology","volume":"16","author":"Hanudel","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"key20210903112719_b83-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40610-019-0110-9","article-title":"Regulation of fibroblast growth factor 23 by iron, EPO, and HIF","volume":"5","author":"Wheeler","year":"2019","journal-title":"Curr Mol Biol Rep"},{"issue":"16011","key":"key20210903112719_b84-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1038\/boneres.2016.11","article-title":"The hypoxia-inducible factor-1\u03b1 activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res"},{"key":"key20210903112719_b85-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MNH.0000000000000514","article-title":"Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease","volume":"28","author":"Babitt","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20210903112719_b86-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/1735-3327.174720","article-title":"Salivary levels of interleukin-6 and tumor necrosis factor-\u03b1 in patients undergoing hemodialysis","volume":"13","author":"Khozeymeh","year":"2016","journal-title":"Dent Res J (Isfahan)"},{"key":"key20210903112719_b87-etm-0-0-10593","first-page":"317","article-title":"Coexistence of micro-inflammatory and macrophage phenotype abnormalities in chronic kidney disease","volume":"13","author":"Wu","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"key20210903112719_b88-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s11255-018-1967-x","article-title":"Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease","volume":"50","author":"Kim","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"key20210903112719_b89-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/ndt\/gft021","article-title":"Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: The potential role of inflammation","volume":"28","author":"Icardi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key20210903112719_b90-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.imlet.2014.11.004","article-title":"1\u03b1,25-Dihydroxyvitamin D3 upregulates HIF-1 and TREM-1 via mTOR signaling","volume":"163","author":"Lee","year":"2015","journal-title":"Immunol Lett"},{"issue":"304","key":"key20210903112719_b91-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00304","article-title":"The EPO-FGF23 signaling pathway in erythroid progenitor cells: Opening a new area of research","volume":"10","author":"van Vuren","year":"2019","journal-title":"Front Physiol"},{"issue":"23","key":"key20210903112719_b92-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0629-6","article-title":"Hypoxia-inducible factor stabilizers: A new avenue for reducing BP while helping hemoglobin?","volume":"18","author":"Yousaf","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"e0176984","key":"key20210903112719_b93-etm-0-0-10593","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176984","article-title":"High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients","volume":"12","author":"Honda","year":"2017","journal-title":"PLoS One"},{"key":"key20210903112719_b94-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1093\/ndt\/gfm316","article-title":"Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease","volume":"22","author":"Artunc","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20210903112719_b95-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210903112719_b96-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210903112719_b97-etm-0-0-10593","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.114.011034","article-title":"Fibroblast growth factor 23: A novel key to find hidden substrates of atrial fibrillation?","volume":"130","author":"Kalyanasundaram","year":"2014","journal-title":"Circulation"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:15:41Z","timestamp":1630955741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":97,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10593","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"article-number":"1159"}}